An Interventional Study to Compare the Efficacy and Tolerability of Current and Slow Titration With TARGIN in the Treatment of Moderate to Severe Non-malignant Chronic Pain (GLORY)

Trial Profile

An Interventional Study to Compare the Efficacy and Tolerability of Current and Slow Titration With TARGIN in the Treatment of Moderate to Severe Non-malignant Chronic Pain (GLORY)

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Oxycodone/naloxone (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Acronyms GLORY
  • Sponsors Mundipharma International
  • Most Recent Events

    • 07 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 09 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 29 Nov 2013 Planned End Date changed from 1 Sep 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top